Skip to main content
Back to glossary index

Marketing authorisation under exceptional circumstances

Specific approval for certain medicines targeting rare diseases or when full data collection is unethical or impossible.

Read related content in the entries on Marketing authorisation under exceptional circumstances of the research pathways.

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts